Quinones are reduced by 6-tetrahydrobiopterin in human keratinocytes, melanocytes, and melanoma cells

Free Radical Biology and Medicine

Volumn 44, Issue 4, 2008, Pages 538-546

  Schallreuter, Karin U ^a,b   Rokos, Hartmut ^a,b   Chavan, Bhaven ^a   Gillbro, Johanna M ^a   Cemeli, Eduardo ^a   Zothner, Carsten ^a,b   Anderson, Diana ^a   Wood, John M ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

6 Tetrahydrobiopterin; Coenzyme Q10; Estrogens; H2O2; Keratinocytes; Melanocytes; Reactive oxygen species

Indexed keywords

ESTRADIOL; HYDROGEN PEROXIDE; HYDROQUINONE; QUINONE DERIVATIVE; RADICAL; REACTIVE OXYGEN METABOLITE; SCAVENGER; SEMIQUINONE; TETRAHYDROBIOPTERIN; THIOREDOXIN REDUCTASE; UBIDECARENONE;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; DNA DAMAGE; EPIDERMIS; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOCYTE; MELANOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REDUCTION;

BIOPTERIN; CELLS, CULTURED; DNA DAMAGE; HUMANS; HYDROGEN PEROXIDE; KERATINOCYTES; MELANOCYTES; MELANOMA; OXIDATION-REDUCTION; QUINONES; THIOREDOXIN-DISULFIDE REDUCTASE;

EID: 38649098487     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.10.043     Document Type: Article

References (43)

1. Anderson D., Schmid T.E., Baumgartner A., Cemeli-Carratala E., Brinkworth M.H., and Wood J.M. Oestrogenic compounds and oxidative stress (in human sperm and lymphocytes in the comet assay). Mutat. Res. 544 (2003) 173-178
2. Schallreuter K.U., Chiuchiarelli G., Cemeli E., Elwary S.M., Gillbro J.M., Spencer J.D., Rokos H., Panske A., Chavan B., Wood J.M., and Anderson D. Estrogens can contribute to hydrogen peroxide generation and quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligo. J. Invest. Dermatol. 126 (2006) 1036-1042
3. Nordberg J., and Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31 (2001) 1287-1312
4. Beyer R.E. The participation of coenzyme Q in free radical production and antioxidation. Free Radic. Biol. Med. 8 (1990) 545-565
5. Ernster L., and Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1271 (1995) 195-204
6. Arndt K.A., and Fitzpatrick T.B. Topical use of hydroquinone as a depigmenting agent. JAMA 194 (1965) 965-967
7. Bucks D.A., McMaster J.R., Guy R.H., and Maibach H.I. Percutaneous absorption of hydroquinone in humans: effect of 1-dodecylazacycloheptan-2-one (azone) and the 2-ethylhexyl ester of 4-(dimethylamino)benzoic acid (Escalol 507). J. Toxicol. Environ. Health 24 (1988) 279-289
8. Wester R.C., Melendres J., Hui X., Cox R., Serranzana S., Zhai H., Quan D., and Maibach H.I. Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition. J. Toxicol. Environ. Health A 54 (1998) 301-317
9. Thöny B., Auerbach G., and Blau N. Tetrahydrobiopterin biosynthesis regeneration and functions. Biochem. J. 347 (2000) 1-16
10. Slominski A., Wortsman J., and Tobin D.J. The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J. 19 (2005) 176-194
11. Jung J.H., Choi S.W., and Han S. Indirect oxidation of 6-tetrahydrobiopterin by tyrosinase. Biochem. Biophys. Res. Commun. 314 (2004) 937-942
12. Spencer J.D., Chavan B., Marles L.K., Kauser S., Rokos H., and Schallreuter K.U. A novel mechanism in control of human pigmentation by {beta}-melanocyte-stimulating hormone and 7-tetrahydrobiopterin. J. Endocrinol. 187 (2005) 293-302
13. Schallreuter K.U., Wood J.M., Pittelkow M.R., Gütlich M., Lemke K.R., Rödl W., Swanson N.N., Hitzemann K., and Ziegler I. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263 (1994) 1444-1446
14. Xia L., Nordman T., Olsson J.M., Damdimopoulos A., Bjorkhem-Bergman L., Nalvarte I., Eriksson L.C., Arner E.S., Spyrou G., and Bjornstedt M. The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. J. Biol. Chem. 278 (2003) 2141-2146
15. Cenas N., Nivinskas H., Anusevicius Z., Sarlauskas J., Lederer F., and Arner E.S. Interactions of quinones with thioredoxin reductase: a challenge to the antioxidant role of the mammalian selenoprotein. J. Biol. Chem. 279 (2004) 2583-2592
16. Damdimopoulos A.E., Miranda-Vizuete A., Treuter E., Gustafsson J.A., and Spyrou G. An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling. J. Biol. Chem. 279 (2004) 38721-38729
17. Ogawa F., Sander C.S., Hansel A., Oehrl W., Kasperczyk H., Elsner P., Shimizu K., Heinemann S.H., and Thiele J.J. The repair enzyme peptide methionine-S-sulfoxide reductase is expressed in human epidermis and upregulated by UVA radiation. J. Invest. Dermatol. 126 (2006) 1128-1134
18. Schallreuter K.U., Rübsam K., Chavan B., Zothner C., Gillbro J.M., Spencer J.D., and Wood J.M. Functioning methionine sulfoxide reductases A and B are present in human epidermal melanocytes in the cytosol and in the nucleus. Biochem. Biophys. Res. Commun. 342 (2006) 145-152
19. Gitler C., Zarmi B., Kalef E., Meller R., Zor U., and Goldman R. Calcium-dependent oxidation of thioredoxin during cellular growth initiation. Biochem. Biophys. Res. Commun. 290 (2002) 624-628
20. Schallreuter K.U., Gleason F.K., and Wood J.M. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim. Biophys. Acta 1054 (1990) 14-20
21. Schallreuter K.U., and Wood J.M. The activity and purification of membrane-associated thioredoxin reductase from human metastatic melanotic melanoma. Biochim. Biophys. Acta 967 (1988) 103-109
22. Wille J.J., Pittelkow M.R., Shipley G.D., and Scott R.E. Integrated control of growth and differentiation of normal human prokeratinocytes cultered in serum-free medium: clonal analyses, growth kinetics and cell cycle studies. J. Cell. Physiol. 121 (1984) 31-44
23. Pittelkow M.R., and Shipley G.D. Serum-free culture of normal human melanocytes: growth kinetics and growth factor requirements. J. Cell. Physiol. 140 (1989) 565-576
24. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J. Investig. Dermatol. Symp. Proc. 4 (1999) 91-96
25. Rokos H. Radioimmunoassay for determination of biopterin. Pteridines 1 (1989) 224-225
26. Singh N.P., McCoy M.T., Tice R.R., and Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175 (1988) 184-191
27. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., and Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35 (2000) 206-221
28. Schallreuter K.U., and Wood J.M. Thioredoxin reductase-its role in epidermal redox status. J. Photochem. Photobiol., B Biol. 64 (2001) 179-184
29. 4). In: Peters G.J., and Jansen G. (Eds). Chemistry and biology of pteridines and folates (2007), SPS Verlagsgesellschaft, Heilbronn 408-422
30. Boyle J., and Kennedy C.T. Hydroquinone concentrations in skin lightening creams. Br. J. Dermatol. 114 (1986) 501-504
31. FDA. Skin bleaching drug products for over-the-counter human use; tentative final monograph (21 CFR Part 358). Fed. Regist. 47 (1982) 39108-39117
32. EC. 24th Commission Directive 2000/6/EC. 2000.
33. FDA. Skin bleaching drug products for over-the-counter human use; proposed rule, withdrawal of previous proposed rule (21 CFR Part 310). Fed. Regist. 71 (2006) 51146-51155
34. Shigenaga M.K., Hagen T.M., and Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 10771-10778
35. Schallreuter K.U. Vitiligo. In: Hertl M. (Ed). Autoimmune diseases of the skin. Pathogenesis, diagnosis, management (2005), Springer, Wien 367-384
36. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., Coskun P.E., Ladiges W., Wolf N., Van Remmen H., Wallace D., and Rabinovitch C. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308 (2005) 1909-1911
37. Schallreuter K.U., Wood J.M., and Berger J. Low catalase levels in the epidermis of patients with vitiligo. J. Invest. Dermatol. 97 (1991) 1081-1085
38. Dell'Anna M.L., Ottaviani M., Albanesi V., Vidolin A.P., Leone G., Ferraro C., Cossarizza A., Rossi L., and Picardo M. Membrane lipid alterations as a possible basis for melanocyte degeneration in vitiligo. J. Invest. Dermatol. 127 (2007) 1226-1233
39. Schallreuter K.U., Wood J.M., Ziegler I., Lemke K.R., Pittelkow M.R., Lindsey N.J., and Gütlich M. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim. Biophys. Acta 1226 (1994) 181-192
40. Schallreuter K.U., Wood J.M., Körner C., Harle K.M., Schulz-Douglas V., and Werner E.R. 6-Tetrahydrobiopterin functions as a UVB-light switch for de novo melanogenesis. Biochim. Biophys. Acta 1382 (1998) 339-344
41. 2 and pterin-6-carboxylic acid. Biochem. Biophys. Res. Commun. 292 (2002) 805-811
42. Schallreuter K.U. Functioning methionine-S-sulfoxide reductases A and B are present in human skin. J. Invest. Dermatol. 126 (2006) 947-949
43. Schallreuter K.U., Hordinsky M.K., and Wood J.M. Thioredoxin reductase. Role in free radical reduction in different hypopigmentation disorders. Arch. Dermatol. 123 (1987) 615-619